{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:44:09Z","timestamp":1789166649669,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002912","name":"Government of Guangdong Province","doi-asserted-by":"publisher","award":["00201503"],"award-info":[{"award-number":["00201503"]}],"id":[{"id":"10.13039\/501100002912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejmech.2021.113267","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T04:44:28Z","timestamp":1612932268000},"page":"113267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["A new class of \u03b1-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities"],"prefix":"10.1016","volume":"215","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boqiang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-6657","authenticated-orcid":false,"given":"Jasper","family":"Fuk-Woo Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuofeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-427X","authenticated-orcid":false,"given":"Jiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina S.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieh","family":"Warshel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-4570","authenticated-orcid":false,"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ciechanover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113267_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2021.113267_bib2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/cr.2016.86","article-title":"The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death","volume":"26","author":"Livneh","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2021.113267_bib3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41580-018-0040-z","article-title":"Regulation of proteasome assembly and activity in health and disease","volume":"19","author":"Rousseau","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113267_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acscentsci.7b00252","article-title":"The proteasome in modern drug discovery: second life of a highly valuable drug target","volume":"3","author":"Cromm","year":"2017","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ejmech.2021.113267_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/386463a0","article-title":"Structure of 20S proteasome from yeast at 2.4\u00c5 resolution","volume":"386","author":"Groll","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113267_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.7725097","article-title":"Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution","volume":"268","author":"L\u00f6we","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113267_bib7","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1021\/bi00497a001","article-title":"The multicatalytic proteinase complex, a major extralysosomal proteolytic system","volume":"29","author":"Orlowski","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113267_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/138920291501140306113344","article-title":"The mechanistic links between proteasome activity, aging and agerelated diseases","volume":"15","author":"Isabel","year":"2014","journal-title":"Curr. Genom."},{"key":"10.1016\/j.ejmech.2021.113267_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.1141915","article-title":"Regulation of CD8+ T cell development by thymus-specific proteasomes","volume":"316","author":"Murata","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113267_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri2687","article-title":"Proteasomes in immune cells: more than peptide producers?","volume":"10","author":"Groettrup","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2021.113267_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A\u00a0selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2021.113267_bib12","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1002\/anie.201201616","article-title":"Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development","volume":"51","author":"Huber","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113267_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2017.09.001","article-title":"Immunoproteasome-selective and non-selective inhibitors: a promising approach for the treatment of multiple myeloma","volume":"182","author":"Ettari","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113267_bib14","first-page":"4996","article-title":"Proteasome inhibitor PS-341 inhibits human myeloma cell growth in\u00a0vivo and prolongs survival in a murine model","volume":"62","author":"LeBlanc","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113267_bib15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-894X(98)00029-8","article-title":"Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids","volume":"8","author":"Adams","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113267_bib16","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2007-01-065888","article-title":"Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma","volume":"110","author":"Kuhn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113267_bib17","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-11-0476","article-title":"In\u00a0vitro and in\u00a0vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells","volume":"17","author":"Chauhan","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113267_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.chembiol.2007.03.008","article-title":"LMP2-Specific inhibitors: chemical genetic tools for proteasome biology","volume":"14","author":"Ho","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113267_bib19","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1073\/pnas.0600647103","article-title":"Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation","volume":"103","author":"Groll","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2021.113267_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1039\/C1CC15273D","article-title":"Exploiting nature\u2019s rich source of proteasome inhibitors as starting points in drug development","volume":"48","author":"Gr\u00e4wert","year":"2012","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113267_bib21","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acs.jmedchem.8b01943","article-title":"Development of novel epoxyketone-based proteasome inhibitors as a strategy to overcome cancer resistance to carfilzomib and bortezomib","volume":"62","author":"Lee","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113267_bib22","doi-asserted-by":"crossref","first-page":"28394","DOI":"10.1074\/jbc.M502453200","article-title":"Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines","volume":"280","author":"Braun","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113267_bib23","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/anie.201308984","article-title":"Systematic comparison of peptidic proteasome inhibitors highlights the \u03b1-ketoamide electrophile as an auspicious reversible lead motif","volume":"53","author":"Stein","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113267_bib24","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/cmdc.201402244","article-title":"alpha-Keto phenylamides as P1\u2019-extended proteasome inhibitors","volume":"9","author":"Voss","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113267_bib25","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1021\/bi025603x","article-title":"Prime site binding inhibitors of a serine Protease: NS3\/4A of hepatitis C virus","volume":"41","author":"Ingallinella","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113267_bib26","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1021\/bi060364p","article-title":"Exploring the S4 and S1 prime subsite specificities in caspase-3 with aza-peptide epoxide inhibitors,","volume":"45","author":"Ganesan","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113267_bib27","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/acs.jmedchem.9b00838","article-title":"HIV-1 protease inhibitors incorporating stereochemically defined P2\u2032 ligands to optimize hydrogen bonding in the substrate envelope","volume":"62","author":"Rusere","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113267_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A\u00a0familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2021.113267_bib29","doi-asserted-by":"crossref","first-page":"12419","DOI":"10.1128\/JVI.01219-10","article-title":"Proteasome inhibition in\u00a0vivo promotes survival in a lethal murine model of severe acute respiratory syndrome","volume":"84","author":"Ma","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113267_bib30","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1128\/JVI.00485-10","article-title":"The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle","volume":"84","author":"Raaben","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113267_bib31","doi-asserted-by":"crossref","first-page":"10112","DOI":"10.1128\/JVI.01001-12","article-title":"Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain","volume":"86","author":"Schneider","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ejmech.2021.113267_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632020401500102","article-title":"Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine","volume":"15","author":"Barnard","year":"2004","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2021.113267_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113267_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2021.113267_bib35","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1002\/ejoc.201101102","article-title":"Methyl 2-furoate: an alternative reagent to furan for palladium-catalysed direct arylation","author":"Fu","year":"2011","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2021.113267_bib36","doi-asserted-by":"crossref","first-page":"11920","DOI":"10.1016\/j.ica.2019.119220","article-title":"Synthesis, structures and catalytic activity of Pd(II) saccharinate complexes with monophosphines in direct arylation of five-membered heteroarenes with aryl bromides","volume":"500","author":"Yilmaz","year":"2020","journal-title":"Inorg. Chim. Acta."},{"key":"10.1016\/j.ejmech.2021.113267_bib37","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/acsmedchemlett.9b00233","article-title":"Synthesis and biological activity of peptide \u03b1-ketoamide derivatives as proteasome inhibitors","volume":"10","author":"Pacifico","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113267_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.chembiol.2018.11.007","article-title":"Proteasome inhibition in multiple myeloma: head-to-head comparison of currently available proteasome inhibitors","volume":"26","author":"Besse","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2021.113267_bib39","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1002\/anie.201406964","article-title":"Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site","volume":"53","author":"Dubiella","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113267_bib40","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1021\/acs.jmedchem.9b00509","article-title":"Design and evaluation of highly selective human immunoproteasome inhibitors reveal a compensatory process that preserves immune cell viability","volume":"62","author":"Ladi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113267_bib41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1126\/science.aaf8993","article-title":"The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design","volume":"353","author":"Schrader","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113267_bib42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2021.113267_bib43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2021.113267_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature07451","article-title":"Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin","volume":"456","author":"Hanna","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113267_bib45","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/cmdc.201900472","article-title":"Cell-based optimization of covalent reversible ketoamide inhibitors bridging the unprimed to the primed site of the proteasome beta5 subunit","volume":"14","author":"Stubba","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113267_bib46","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-018-08015-x","article-title":"SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target","volume":"10","author":"Yuan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113267_bib47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/v12060628","article-title":"Broad-Spectrum host-based antivirals targeting the interferon and lipogenesis pathways as potential treatment options for the pandemic coronavirus disease 2019 (COVID-19)","volume":"12","author":"Yuan","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2021.113267_bib48","doi-asserted-by":"crossref","first-page":"104960","DOI":"10.1016\/j.phrs.2020.104960","article-title":"Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system","volume":"159","author":"Yuan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113267_bib49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.ejmech.2021.113267_bib50","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1021\/acs.jpcb.0c04435","article-title":"Exploring the proteolysis mechanism of the proteasomes","volume":"124","author":"Saha","year":"2020","journal-title":"J.\u00a0Phys. Chem. B."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:24:47Z","timestamp":1759328687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":50,"alternative-id":["S0223523421001161"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113267","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new class of \u03b1-ketoamide derivatives with potent anticancer and anti-SARS-CoV-2 activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113267"}}